Anuh pharma share price

• The company has significantly decreased its debt by 10.4867 Cr. • Company is virtually debt free. • Company has a healthy Interest coverage ratio of 25.7623267295398. • The company has an efficient Cash Conversion Cycle of 32.718750487925 days. • The company has a high promoter holding of 70.58%. • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.79120016762807. Quarterly Result (All Figures in Cr.) PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Net Sales 128.97 116.38 115.07 138.73 157.31 Total Expenditure 115.1 105.19 101.64 126.3 143.08 Operating Profit 13.87 11.19 13.43 12.43 14.23 Other Income 1.03 0.96 2.01 2.11 1.04 Interest -0.18 0.06 0.11 0.03 0.02 Depreciation 3.01 2.42 2.44 2.43 2.41 Exceptional Items 0 0 0 0 0 Profit Before Tax 12.07 9.66 12.89 12.08 12.84 Tax 3.14 2.33 2.97 2.77 3.22 Profit After Tax 8.93 7.34 9.92 9.31 9.62 Adjusted EPS (Rs) 1.78 1.46 1.98 1.86 1.92 Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.) PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Net Sales 238.09 320.66 306.96 431.96 486.65 Total Expenditure 219.77 290.7 283.73 386.84 439.18 Operating Profit 18.32 29.96 23.23 45.12 47.46 Other Income 7.38 4.7 4.21 10.54 5.2 Interest 0.45 0.6 1.26 2.03 1.58 Depreciation 1.83 1.66 7.03 15.08 11.96 Exceptional Items 0 0 0 0 0 Profit Before Tax 23.42 32.4 19.16 38.55 39.12 Tax 6.9 9.04 4.85 10.12 8.56 Net Profit 16.51 23.37 14.31 28.44 30.56 Adjusted EPS (Rs.) 3.3 4.66 2.85 5.6...

NAME P/E (x) P/B (x) ROE % ROCE % ROA % Rev CAGR [3Yr] OPM NPM Basic EPS Current Ratio Total Debt/ Equity (x) Total Debt/ CFO (x) 16.24 2.44 14.99 19.57 8.93 19.48 9.04 6.85 7.22 1.91 0.00 0.00 19.03 2.23 11.70 17.42 4.77 17.58 12.04 6.39 15.59 1.17 1.13 0.00 10.77 1.56 14.50 19.89 12.41 10.15 20.08 14.28 36.40 5.08 0.00 0.00 37.27 2.93 7.83 11.21 5.31 4.22 13.23 8.94 0.24 1.61 0.32 0.00 101.88 16.84 16.51 23.61 8.28 16.57 7.72 5.15 0.87 1.55 0.22 0.00 Add More • Stock Returns vs Nifty Smallcap 100 Stock gave a 3 year return of 3.01% as compared to Nifty Smallcap 100 which gave a return of 141.43%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated 3.01% return as compared to Nifty Pharma which gave investors 30.16% return over 3 year time period. (as of last trading session) Meeting Date Announced on Purpose Details May 19, 2023 May 11, 2023 Board Meeting Audited Results & Final Dividend Feb 10, 2023 Feb 03, 2023 Board Meeting Quarterly Results Nov 07, 2022 Oct 31, 2022 Board Meeting Quarterly Results Aug 05, 2022 Jul 27, 2022 Board Meeting Quarterly Results May 14, 2022 May 09, 2022 Board Meeting Audited Results & Final Dividend • All Types Ex-Date Record Date Announced on Details Bonus Sep 18, 2020 Sep 21, 2020 Aug 07, 2020 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Aug 05, 2015 Aug 06, 2015 Jun 12, 2015 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Oct 28, 2010 Oct 29, 2010 Aug 06, 2010 Bonus Ratio: 2 share(s) for every 1 sh...

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders. It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments. The main components of the CFS are cash from three areas: operating, investing, and financing activities... A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend. The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out: A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and man...

Sector Healthcare Compare with Sector peers Industry Pharmaceuticals & Drugs Compare with Industry peers Website http://www.anuhpharma.com Market Cap 587.56 Cr. Enterprise Value(EV) 580.91 Cr. 2023-03 Financial Indicators • Standalone Earnings per share (EPS) 7.22 Trailing Twelve Months Ending 2023-03 Price-Earning Ratio (PE) 16.24 Trailing Twelve Months Ending 2023-03 Industry PE 34.47 Trailing Twelve Months Ending 2023-03 Book Value / Share 48.14 Trailing Twelve Months Ending 2023-03 Price to Book Value 2.44 Calculated using Price: 117.25 Dividend Yield 1.71 Period Ending 2022-03 No. of Shares Subscribed 5.01 Cr. 50,112,000 Shares FaceValue 5 About Anuh Pharma Ltd. Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations. 9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 Return on Equity (%) 21.78 23.55 23.44 15.43 11.38 14.87 8.75 16.12 15.11 Return on Capital Employed (%) 32.94 35.13 34.91 21.61 16.31 20.56 10.87 19.75 19.33 Return on Assets (%) 11.75 13.29 14.37 10.58 8.35 10.44 5.06 8.63 8.99 Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr. Shh. Funds 86 101 119 141 150 165 162 1...